Cas:63001-81-0 Ethyl 6-oxo-1,6-dihydropyridazine-3-carboxylate manufacturer & supplier

Chemical Name:Ethyl 6-oxo-1,6-dihydropyridazine-3-carboxylate

CAS.NO:63001-81-0

Synonyms:Ethyl 6-oxo-1,6-dihydropyridazine-3-carboxylate

Molecular Formula:C₇H₈N₂O₃

Molecular Weight:168.15000

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:72.05000

Exact Mass:168.05300

LogP:

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Ethyl 6-oxo-1,6-dihydropyridazine-3-carboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Ethyl 6-oxo-1,6-dihydropyridazine-3-carboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Ethyl 6-oxo-1,6-dihydropyridazine-3-carboxylate Use and application,Ethyl 6-oxo-1,6-dihydropyridazine-3-carboxylate technical grade,usp/ep/jp grade.

Related News: The firm also has several lawyers whose reputations would carry weight with the Justice Department and the FDA, including former Attorney General Eric Holder, legal experts said. Gerald Masoudi, the Covington partner who handled the recent inquiry for Lilly, once served as the FDA’s chief counsel. Masoudi did not respond to requests for comment. Ethyl 6-oxo-1,6-dihydropyridazine-3-carboxylate manufacturer The firm also has several lawyers whose reputations would carry weight with the Justice Department and the FDA, including former Attorney General Eric Holder, legal experts said. Gerald Masoudi, the Covington partner who handled the recent inquiry for Lilly, once served as the FDA’s chief counsel. Masoudi did not respond to requests for comment. Ethyl 6-oxo-1,6-dihydropyridazine-3-carboxylate supplier Villages and cities in China have resorted to flying drones with speakers to patrol streets and scold people not wearing masks in public amid the coronavirus outbreak, according to Chinese state media. Ethyl 6-oxo-1,6-dihydropyridazine-3-carboxylate vendor The U.S. Food & Drug Administration on Friday said Johnson & Johnson (JNJ.N) must throw away millions of doses of its COVID-19 vaccine that were manufactured at a problem-plagued Baltimore factory but also cleared millions for use. Ethyl 6-oxo-1,6-dihydropyridazine-3-carboxylate factory Without disclosing or confirming the number of vaccine doses, the FDA said in a news release that it had authorized two batches of the vaccine for use, that several other batches were not suitable for use and that others were being evaluated.